167 related articles for article (PubMed ID: 32108545)
1. Interrater Reliability of Dynamic Muscle Testing After Breast Cancer Surgery in Women at High Risk of Lymphedema: To Improve Quality in Clinical Practice.
Korsholm-Rosfort T; Larsen S; Aagaard T; Ammitzbøll G; Dalton SO
Integr Cancer Ther; 2020; 19():1534735420903801. PubMed ID: 32108545
[No Abstract] [Full Text] [Related]
2. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
3. Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial.
Ammitzbøll G; Johansen C; Lanng C; Andersen EW; Kroman N; Zerahn B; Hyldegaard O; Wittenkamp MC; Dalton SO
Cancer; 2019 May; 125(10):1683-1692. PubMed ID: 30633334
[TBL] [Abstract][Full Text] [Related]
4. Shoulder Strength Changes One Year After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Patients With Breast Cancer.
Monleon S; Ferrer M; Tejero M; Pont A; Piqueras M; Belmonte R
Arch Phys Med Rehabil; 2016 Jun; 97(6):953-63. PubMed ID: 26763950
[TBL] [Abstract][Full Text] [Related]
5. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
6. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
7. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
8. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
10. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
11. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
12. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
[TBL] [Abstract][Full Text] [Related]
13. Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study.
Baschung Pfister P; de Bruin ED; Sterkele I; Maurer B; de Bie RA; Knols RH
PLoS One; 2018; 13(3):e0194531. PubMed ID: 29596450
[TBL] [Abstract][Full Text] [Related]
14. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
[TBL] [Abstract][Full Text] [Related]
15. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema.
Deltombe T; Jamart J; Recloux S; Legrand C; Vandenbroeck N; Theys S; Hanson P
Lymphology; 2007 Mar; 40(1):26-34. PubMed ID: 17539462
[TBL] [Abstract][Full Text] [Related]
16. Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review.
Gebruers N; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():117-22. PubMed ID: 27019287
[TBL] [Abstract][Full Text] [Related]
17. Axillary reverse mapping (ARM): where to go.
Shao X; Sun B; Shen Y
Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
[TBL] [Abstract][Full Text] [Related]
18. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
19. The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
Lee SB; Gwark SC; Kang CM; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Ahn SH; Kim W; Do J; Jeon JY; Kim J; Um E; Yoon TI; Jung SU; Han M; Son BH
PLoS One; 2020; 15(9):e0238284. PubMed ID: 32966294
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]